By Dr Khushboo Sethia · Dermatologist, SkinWise Clinic Published Last reviewed
Vitiligo: causes, symptoms and honest treatment options for Indian skin
A small pale patch on the corner of the lip. A faint white area on the hand. A streak through the eyebrow that wasn’t there a year ago. By the time most patients sit down across from us, vitiligo has been with them for months — sometimes years — usually with the same set of questions. Will it spread? Will it come back to normal? Is it contagious? Does this mean something is wrong inside?
Vitiligo lives at a complicated intersection of dermatology, autoimmunity, and — particularly in Indian society — visible identity. It carries more social weight than its medical severity warrants, and it gets treated less actively than the available evidence supports. There’s no permanent cure yet. But the treatment landscape has changed meaningfully in the last five years, and a significant proportion of patients can achieve substantial repigmentation with the right plan, started early.
Here’s how we approach vitiligo at SkinWise — honestly, in plain language, and with the dignity the condition deserves.
What vitiligo actually is
Vitiligo is an autoimmune condition in which the immune system targets melanocytes — the cells in the skin that produce melanin. The follicle isn’t destroyed; the melanocyte is. Skin in the affected area loses its pigment over weeks to months, leaving white or very pale patches.
A few things to anchor:
- It’s not contagious. It does not spread from person to person — not by touch, not by sharing utensils, not by clothes.
- It’s not caused by diet. Specific food combinations (fish and milk, sour foods, etc.) commonly blamed in Indian households do not cause vitiligo. Period.
- It’s not a sign of internal disease in most cases. Patients are sometimes told vitiligo signals “something inside” — this misframing causes years of unnecessary anxiety. There are real autoimmune associations (thyroid disease, type 1 diabetes, alopecia areata) that we screen for, but the vast majority of patients with vitiligo are otherwise healthy.
- It’s not skin cancer. It’s not a malignancy of any kind, and it doesn’t turn into cancer.
- It is treatable. The treatments aren’t magic; they aren’t fast; they aren’t universally successful. But they exist, and they’ve improved.
About 0.5–2% of the Indian population has vitiligo. It can start at any age — though the most common windows are childhood, adolescence, and the third decade.
What it looks like
- White or very pale patches of skin, well-defined edges
- Can appear anywhere; favourite sites include the face (around the mouth, eyes, eyebrows), hands and fingertips, elbows, knees, ankles, feet, genitals, body folds (axillae, groin)
- Hair within an affected patch may turn white or grey (leukotrichia)
- Frequently symmetric on both sides of the body in non-segmental vitiligo
- Occasionally asymmetric and following a nerve distribution in segmental vitiligo
- May involve mucosal surfaces (lips, inside of mouth)
In Indian skin (Fitzpatrick III–V), the contrast between vitiligo and surrounding skin is high — which is why the condition is more visually prominent, and unfortunately more socially scrutinised, in our population than in Fitzpatrick I–II skin.
The two main patterns
The pattern affects prognosis and treatment.
Non-segmental vitiligo (NSV) — the most common form. Symmetrical patches on both sides of the body, typically progressing in episodic flares. Often associated with autoimmune conditions. Responsive to medical therapy in many patients.
Segmental vitiligo (SV) — patches confined to one side of the body in a nerve-related distribution. Usually starts in childhood or adolescence, progresses for 1–2 years, then stabilises. Less commonly associated with autoimmune conditions. Often a stronger candidate for surgical pigment-transfer techniques once stable.
There are also several sub-types — acrofacial (face and extremities), focal (one or two patches), universal (widespread) — each with slight differences in trajectory.
What triggers it
The honest answer is that vitiligo is a multifactorial autoimmune process, and a single specific trigger usually can’t be identified. What we know:
- Genetic predisposition. First-degree relatives of patients with vitiligo have a meaningfully increased risk. It’s polygenic — not single-gene Mendelian — so most children of vitiligo patients do not develop it.
- Autoimmune background. Often coexists with autoimmune thyroid disease, alopecia areata, type 1 diabetes, pernicious anaemia. We screen.
- Skin trauma (Koebner phenomenon). New vitiligo patches sometimes appear at sites of cuts, friction, burns, tight clothing, tattoos.
- Sunburn or chemical exposure. Some phenolic chemicals (in industrial settings, hair dyes, certain rubber products) can trigger or worsen vitiligo in susceptible patients.
- Severe physical or emotional stress. Anecdotally common as a precipitating event; harder to prove rigorously.
Things that are not causes of vitiligo:
- Specific foods (despite cultural beliefs)
- Calcium deficiency
- “Cold drinks after hot food”
- Hygiene
- Anything you did wrong
What we test for
A focused, indication-led workup — not a 30-test panel:
- Thyroid function (TSH, anti-TPO)
- CBC and screening labs depending on history
- Vitamin D, B12 levels in some cases
- Wood’s lamp examination in clinic to confirm the extent (subtle patches are often more visible under Wood’s light than in regular light)
Our approach to vitiligo at SkinWise
The plan depends on:
- How much of the body surface is involved
- Where the patches are (face responds best; hands and feet are slowest)
- Whether the disease is actively spreading or stable
- The patient’s age and broader health
- How motivated the patient is — most treatments require sustained commitment
Step 1: stop the active spread
For actively progressing vitiligo, halting new patches comes first.
- Topical corticosteroids (mid-to-high potency for limited periods)
- Topical calcineurin inhibitors (tacrolimus, pimecrolimus) — particularly for the face and folds where steroids are problematic
- Newer topical JAK inhibitors (ruxolitinib cream) — an important recent addition where access permits; well-studied for facial repigmentation
- Short courses of systemic corticosteroids in mini-pulses for rapidly spreading disease
- Antioxidant supplementation (vitamin C, vitamin E, polypodium leucotomos) as adjunct
- Address any identified Koebner-prone sites (tight clothing, friction)
Step 2: drive repigmentation
Once the disease is stable or stabilising:
Phototherapy
- Narrowband UVB (NB-UVB) — the workhorse of vitiligo treatment. In-clinic sessions, typically 2–3 times a week, over months. Strong evidence; well tolerated in our patient base. Better response on face and trunk than hands and feet.
- Targeted phototherapy / excimer laser for limited patches
- Sun-exposure protocols in selected cases under guidance
Topical and combined regimens
- Continuing topical calcineurin inhibitors or topical JAK inhibitors with phototherapy is often more effective than either alone
- Daily sun protection on uninvolved skin to reduce contrast
- Regular emollients and barrier care
Surgical pigment-transfer techniques
For stable, refractory patches — usually segmental vitiligo or localised stable non-segmental patches:
- Suction blister grafting
- Mini punch grafting
- Non-cultured epidermal cell suspension transplant (NCECS / Melanocyte transplantation)
These transfer pigment cells from an unaffected donor site to the depigmented area. Done correctly in well-selected patients, they can produce strikingly even repigmentation. Done in unstable disease, they often fail or even trigger Koebner-phenomenon depigmentation at the donor site.
Step 3: realistic, patient-led aesthetic options
- Cosmetic camouflage — high-quality concealers and tinted formulations, used skilfully, can be transformative for visible patches in social or professional life. We don’t treat this as “giving up” — it’s a legitimate tool.
- Self-tanning lotions can offer temporary cosmetic blending
- Permanent micropigmentation in carefully selected cases (e.g. stable lip vitiligo)
Step 4: emotional and social support
The visible and social weight of vitiligo, particularly in India, is real. We talk about it openly, signpost mental-health support when needed, and don’t pretend the medical treatment alone is the whole answer.
Step 5: long-term monitoring
- Periodic review to catch new patches or relapses early
- Screening for associated autoimmune conditions over time
- Adjusting the treatment plan as the disease evolves
What not to do
- Don’t pursue “miracle cures.” Online claims of dramatic repigmentation in weeks — herbal pastes, gemstone water, untested supplements — drain time and money. The medical timeline for vitiligo is months to years, not weeks.
- Don’t apply potent topical steroids to the face for months on end. Skin thinning, telangiectasia, and steroid-induced acne are real. Stewardship matters.
- Don’t blame yourself or your diet. Vitiligo isn’t caused by anything you did.
- Don’t avoid medical evaluation because you’ve been told there’s no treatment. That advice was true 30 years ago. The landscape today is very different.
- Don’t accept a clinic that only sells you a long course of an expensive topical without examining you, screening for associated conditions, or planning a phototherapy element.
- Don’t expect repigmentation on hands and feet to match the face. Acral sites are biologically less responsive. We tell patients this upfront.
- Don’t get a tattoo or permanent makeup over a vitiligo patch in active disease. Koebner phenomenon can drive new patches at the trauma site.
Frequently asked questions
Will my vitiligo spread? Hard to predict in any individual. Some patients have one or two patches and never develop more. Others have episodic flares of new patches over years. Active treatment significantly reduces the risk of progression.
Will my children get it? There’s a small increased risk, not a high one. Even in identical twins, both don’t always develop vitiligo — strong evidence that genetics is only part of the picture.
Is it linked to thyroid problems? There’s a real association — about 10–20% of vitiligo patients have autoimmune thyroid disease. We screen at the first visit.
Can sun exposure cure it? Controlled UVB phototherapy is a major treatment. Casual sunbathing is not a substitute — it risks burns, uneven results, and longer-term skin damage. We deliver UVB in a planned, monitored way.
Is vitiligo painful or itchy? Most vitiligo is asymptomatic. Some patients describe mild itch during an active spreading phase.
Can I have repigmentation surgery? Possibly — if you have stable disease (no new patches for at least a year) and the patches are in suitable sites. We assess case by case.
What about JAK inhibitors I’ve read about? Topical ruxolitinib has approved data for repigmentation, particularly on the face. Oral JAK inhibitors are being studied for more extensive disease. We discuss these openly when they fit — they’re not first-line for everyone but a genuine option in selected cases.
What about pregnancy? We adjust treatment during pregnancy and breastfeeding — phototherapy is generally compatible; some systemic and topical agents are not. We plan around it.
Is the white hair within a patch a bad sign? Yes, in the sense that follicular melanocytes are the reservoir for repigmentation. Patches with retained pigmented hair respond better than patches where the hair has gone white. We use this in planning.
Does diet matter at all? Adequate vitamin D, antioxidants, and overall good nutrition support general skin and immune health. No specific food causes or cures vitiligo. Restrictive diets without indication are unhelpful.
Where to go from here
If you’ve noticed white or pale patches that aren’t fading, that are spreading, or that have been there for months and you’d like a clear plan — book a consultation. We’ll examine in clinic and under Wood’s lamp, screen for associated conditions, and discuss a treatment plan matched to the pattern, location, and your priorities.
If you’ve been told nothing can be done, please consider a second opinion. The honest answer is more hopeful than that.
Related reading: